StockNews.com Begins Coverage on ReWalk Robotics (NASDAQ:RWLK)

StockNews.com initiated coverage on shares of ReWalk Robotics (NASDAQ:RWLK) in a research note published on Wednesday morning. The brokerage issued a sell rating on the medical device company’s stock.

ReWalk Robotics Price Performance

The stock has a market capitalization of $63.04 million, a P/E ratio of -2.84 and a beta of 2.30. The business’s 50-day moving average price is $0.93 and its two-hundred day moving average price is $0.79. ReWalk Robotics has a twelve month low of $0.56 and a twelve month high of $1.30.

Hedge Funds Weigh In On ReWalk Robotics

Several institutional investors and hedge funds have recently modified their holdings of RWLK. Mercer Global Advisors Inc. ADV raised its stake in shares of ReWalk Robotics by 208.3% during the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 44,403 shares of the medical device company’s stock worth $34,000 after buying an additional 30,000 shares during the period. Renaissance Technologies LLC purchased a new position in shares of ReWalk Robotics in the first quarter worth about $35,000. Virtu Financial LLC boosted its holdings in shares of ReWalk Robotics by 249.6% during the 4th quarter. Virtu Financial LLC now owns 47,638 shares of the medical device company’s stock worth $36,000 after purchasing an additional 34,013 shares during the last quarter. Millennium Management LLC boosted its stake in ReWalk Robotics by 42.9% during the fourth quarter. Millennium Management LLC now owns 139,009 shares of the medical device company’s stock worth $106,000 after buying an additional 41,753 shares during the last quarter. Finally, Kent Lake Capital LLC acquired a new position in shares of ReWalk Robotics during the 4th quarter valued at about $532,000. Hedge funds and other institutional investors own 3.58% of the company’s stock.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic.